|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.7 USD | +1.91% |
|
+1.58% | -4.90% |
| 07-15 | Equity Markets Higher After Fed Chair Powell's Comments | MT |
| 07-15 | Equity Markets Rise Intraday After Fed Chair Powell's Comments | MT |
Abbott Laboratories reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 43,653 million compared to USD 43,075 million a year ago. Net income was USD 6,933 million compared to USD 7,071 million a year ago.
Diluted earnings per share from continuing operations was USD 3.91 compared to USD 3.94 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.90% | 179B | |
| -1.36% | 100B | |
| -7.64% | 46.16B | |
| +18.16% | 44.81B | |
| +9.63% | 44.38B | |
| +13.63% | 29.53B | |
| +22.31% | 25.83B | |
| -7.12% | 23.97B | |
| +4.03% | 22.5B | |
| -8.75% | 22.11B |
ABBOTT LABORATORIES 
